 | PEVE - Penta Valent Tbk. | PEVE - Penta Valent Tbk. | PEVE - Penta Valent Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (3) | : | COMPOSITE, ISSI, DBX | ||
| Index (3) | : | COMPOSITE, ISSI, DBX | ||
| Board | : | 3 Index COMPOSITE, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
| Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
| Corporate Action | : | - | ||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | |
|||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 5 | |
| Rating ROA | 3 | |
| Rating EQUITY | 4 | |
| Rating ROE | 2 | |
| Rating DER | 3 | |
| Rating TOTAL | 4 | |
| MARKET CAPITALIZATION | ||
| Listed Share | 1.765.625.000 | |
| Price | Rp. 288 | |
| Capitalization | Rp. 508.500.000.000 | |
| OWNERSHIP | ||
| Listing Date : 24-Jan-23 | ||
| Lokal 59,46 % | Asing 0,19 % | Lainnya 40,35 % |
| PEVE - Penta Valent Tbk. | PEVE - Penta Valent Tbk. | PEVE - Penta Valent Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (3) | : | COMPOSITE, ISSI, DBX | ||
| Index (3) | : | COMPOSITE, ISSI, DBX | ||
| Board | : | 3 Index COMPOSITE, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
| Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
| Corporate Action | : | - | ||
Financial Statements
| Description | 3Q23 | 3Q24 | CAGR 5Y(%) | |||||
| Last Price | 151 | 234 | ||||||
| Market Cap | 266.6 B | 413.2 B | 54.99 | |||||
| BALANCE SHEET | ||||||||
| Cash | 8.0 B | 6.7 B | -16.25 | |||||
| Total Asset | 897.6 B | 1.1 T | 22.55 | |||||
| S.T.Borrowing | 638.7 B | 792.7 B | ||||||
| L.T.Borrowing | 37.8 B | 46.0 B | ||||||
| Total Equity | 221.0 B | 264.3 B | 19.59 | |||||
| INCOME STATEMENT | ||||||||
| Revenue | 1.8 T | 2.2 T | 22.22 | |||||
| Gross Profit | 218.8 B | 263.2 B | 20.29 | |||||
| Operating Profit | 33.8 B | 6.9 B | -79.59 | |||||
| Net.Profit | 24.4 B | 32.0 B | 31.15 | |||||
| EBITDA | 37.4 B | 12.7 B | -66.04 | |||||
| Interest Expense | 3.1 B | 5.4 B | ||||||
| RATIO | ||||||||
| EPS | 13.56 | 17.8 | 31.27 | |||||
| PER | 11.14 x | 13.14 x | ||||||
| BVPS | 125.19 | 149.67 | ||||||
| PBV | 1.21 x | 1.56 x | ||||||
| ROA | 0.0272 | 0.0291 | 6.99 | |||||
| ROE | 0.1104 | 0.1213 | 9.87 | |||||
| EV/EBITDA | 24.97 | 97.96 | ||||||
| Debt/Equity | 3.06 | 3.17 | ||||||
| Debt/TotalCap | 0.75 | 0.76 | ||||||
| Debt/EBITDA | 18.07 | 65.98 | ||||||
| EBITDA/IntExps | 12.04 | 2.36 | -80.40 | |||||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | |
|||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| MARKET CAPITALIZATION | ||
| Listed Share | 1.765.625.000 | |
| Price | Rp. 288 | |
| Capitalization | Rp. 509 B. | |
| OWNERSHIP | ||
| Listing Date : 24-Jan-23 | ||
| Lokal 59,46 % | Asing 0,19 % | Lainnya 40,35 % |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 5 | |
| Rating ROA | 3 | |
| Rating EQUITY | 4 | |
| Rating ROE | 2 | |
| Rating DER | 3 | |
| Rating TOTAL | 4 | |
EARNING PER SHARE
| PEVE - Penta Valent Tbk. | PEVE - Penta Valent Tbk. | PEVE - Penta Valent Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (3) | : | COMPOSITE, ISSI, DBX | ||
| Index (3) | : | COMPOSITE, ISSI, DBX | ||
| Board | : | 3 Index COMPOSITE, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
| Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
| Corporate Action | : | - | ||
| TIME PERIOD : 07-03-2025 | |||
| Close | 288 | Prev Close | 292 |
| Change | -4 (-1.4%) | Range | 286-294 |
| Bid | 288 | Offer | 292 |
| Bid Volume | 46700 | Offer Volume | 10000 |
| Frequency | 70 | Value Rp.: 83.617.000 | |
| EARNING PER SHARE (% PRICE) | |||||
|---|---|---|---|---|---|
| Benchmark to Others : | |||||
| A Exceptional | |||||
| B Excellent | |||||
| C Very Good | |
||||
| D Good | |||||
| E Fair | |||||
| F Poor | |||||
| Percent (%) of Price |
≤ 0 |
0-1.05 | 1.05-2.3 | 2.3-4.23 | > 4.23 |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | |
|||||
| D Good | ||||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |